文献速递脑血管病

抑制免疫检查点B7-H3可重编程急性神经炎症并保护缺血性卒中后脑组织

Immune Checkpoint B7-H3 Inhibition Reprograms Acute Neuroinflammation and Protects the Brain After Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2026-09-03

该研究在小鼠短暂性大脑中动脉闭塞模型中,于再灌注后5分钟静脉注射B7-H3小干扰RNA或阴性对照,并在卒中后1、3、7天用9.4-T磁共振评估脑损伤与血脑屏障完整性。结果显示早期抑制B7-H3显著减轻血脑屏障破坏和脑损伤并促进功能结局,同时重编程卒中后神经炎症以平衡神经保护性抗炎机制而不损害免疫反应。

要点

  • 急性缺血性卒中后早期抑制B7-H3可减轻血脑屏障破坏与脑损伤。
  • B7-H3抑制可重编程卒中后神经炎症,平衡抗炎保护而不损害宿主防御。
  • 早期抑制B7-H3促进卒中后运动功能结局。

核心结论

  • 急性缺血性卒中后急性期B7-H3的诱导介导卒中后神经炎症和继发性脑损伤。
  • 早期抑制B7-H3可重编程神经炎症、减轻血脑屏障破坏和脑损伤并促进功能结局。

研究设计与样本

  • C57BL/6小鼠接受短暂性大脑中动脉闭塞,再灌注后5分钟静脉注射B7-H3小干扰RNA或阴性对照小干扰RNA。
  • 卒中后1、3、7天用9.4-T磁共振评估脑损伤(T2、表观扩散系数、峰度)和血脑屏障完整性(T1增强)。
  • 用实时定量聚合酶链反应和NanoString nCounter神经炎症面板检测B7-H3介导的急性神经炎症功能变化。
  • 再灌注后1至7天评估运动功能。

主要发现

  • 早期抑制B7-H3显著减少血脑屏障破坏和脑损伤并促进功能结局。
  • B7-H3抑制重编程卒中后神经炎症,平衡神经保护性抗炎机制而不损害免疫反应。

临床怎么用

  • B7-H3可作为急性缺血性卒中后神经炎症和继发性脑损伤的潜在干预靶点。
  • 靶向B7-H3可能在不损害卒中后抗感染免疫的前提下提供神经保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of immune checkpoint B7-H3 in acute ischemic stroke prognosis and poststroke immunosuppression remains uninvestigated, despite the clinical significance of immune checkpoints with inflammaging and poststroke infections. In this study, we investigated the effect of regulating cerebral induction of B7-H3 after acute ischemic stroke and evaluated its longitudinal impact on brain damage, neuroinflammation, vascular integrity, host defense gene regulation, and functional outcomes. METHODS: C57BL/6 mice were subjected to transient middle cerebral artery occlusion and injected (intravenously) with either B7-H3 small interfering RNA or a negative (nontargeting) small interfering RNA at 5 minutes after reperfusion. On poststroke days 1, 3, and 7, magnetic resonance imaging of the mouse brain was performed using a 9.4-T scanner to assess brain damage (T2, apparent diffusion coefficient, and kurtosis) and blood-brain barrier integrity (T1 with contrast). Real-time quantitative polymerase chain reaction and NanoString nCounter neuroinflammation panels were used to determine acute changes in overall neuroinflammatory functions mediated by B7-H3. Motor function was assessed between days 1 and 7 of reperfusion. RESULTS: Early inhibition of B7-H3 after stroke significantly reduced blood-brain barrier disruption and brain damage and promoted functional outcomes. Poststroke neuroinflammation was reprogrammed with B7-H3 inhibition to balance neuroprotective anti-inflammatory mechanisms without compromising the immune response, which is crucial for preventing poststroke infections. CONCLUSIONS: The longitudinal assessment of blood-brain barrier, infarction, and proinflammatory cytokines demonstrates that B7-H3 induction during the acute period after stroke mediates poststroke neuroinflammation and secondary brain damage.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Boda AK, Mak KK, Li W, et al. Immune Checkpoint B7-H3 Inhibition Reprograms Acute Neuroinflammation and Protects the Brain After Acute Ischemic Stroke. Stroke. 2026. PMID: 42689339. doi:10.1161/STROKEAHA.126.055713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。